{"content":"<li class=\"n-box-item date-title\" data-end=\"1496289599\" data-start=\"1496203200\" data-txt=\"Monday, December 23, 2019\">Wednesday, May 31, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3270864\" data-ts=\"1496286542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNK\" target=\"_blank\">TNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270864-teekay-tankers-bolsters-fleet-all-stock-deal-for-tanker-investments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teekay Tankers bolsters fleet with all-stock deal for Tanker Investments</a></h4><ul><li>Teekay Tankers (NYSE:<a href='https://seekingalpha.com/symbol/TNK' title='Teekay Tankers Ltd'>TNK</a>) <font color='green'>+10.1%</font>&nbsp;AH after <a href=\"https://seekingalpha.com/pr/16848842-teekay-tankers-announces-merger-agreement-tanker-investments-ltd\" target=\"_blank\">agreeing to acquire</a> the remaining shares of Oslo-listed Tanker Investments in  share-for-share merger resulting in combined total assets of $2.4B; TNK already owned 11.3% of Tanker Investments.</li><li>TNK says Tanker Investments' fleet consists of 10 Suezmax tankers, six Aframax tankers and two LR2  Product tankers with an average age of 7.3 years; following the deal, its fleet will consist of 62 conventional tankers, including three in-chartered conventional tankers.</li><li>TNK expects the deal to be immediately accretive to earnings.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270864\" data-linked=\"Teekay Tankers bolsters fleet with all-stock deal for Tanker Investments\" data-tweet=\"$TNK - Teekay Tankers bolsters fleet with all-stock deal for Tanker Investments https://seekingalpha.com/news/3270864-teekay-tankers-bolsters-fleet-all-stock-deal-for-tanker-investments?source=tweet\" data-url=\"https://seekingalpha.com/news/3270864-teekay-tankers-bolsters-fleet-all-stock-deal-for-tanker-investments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270857\" data-ts=\"1496272587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAG\" target=\"_blank\">CAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270857-pinnacle-foodsplus-7_1-on-report-of-conagra-buyout-approach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinnacle Foods +7.1% on report of Conagra buyout approach</a></h4><ul>   <li>Conagra Brands (NYSE:<a href='https://seekingalpha.com/symbol/CAG' title='ConAgra Brands, Inc.'>CAG</a>) has made a <a href=\"http://www.reuters.com/article/us-pinnacle-foods-m-a-conagra-brands-exc-idUSKBN18R3DP\" target=\"_blank\">buyout approach</a> to Pinnacle Foods (<a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a> <font color='green'>+2.7%</font>), Reuters reports.</li>    <li>That would mean another approach to buying out the packaged-food maker for Conagra chief Sean Connolly, who tried to buy Pinnacle Foods when he was leading a buyout effort at the helm of Hillshire Brands. That $4.3B deal was canceled after Hillshire decided to sell itself to Tyson Foods for $7.7B, Reuters notes.</li>    <li>Pinnacle Foods is <font color='green'>up 7.1%</font> after hours; Conagra Brands is flat postmarket.</li>    <li>Pinnacle has a market cap of $7.2B, while Conagra has a value of $16.2B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270857\" data-linked=\"Pinnacle Foods +7.1% on report of Conagra buyout approach\" data-tweet=\"$CAG $CAG $PF - Pinnacle Foods +7.1% on report of Conagra buyout approach https://seekingalpha.com/news/3270857-pinnacle-foodsplus-7_1-on-report-of-conagra-buyout-approach?source=tweet\" data-url=\"https://seekingalpha.com/news/3270857-pinnacle-foodsplus-7_1-on-report-of-conagra-buyout-approach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270849\" data-ts=\"1496266538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270849-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a> <font color='green'>+12.5%</font>. <a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a> <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/TA' title='TravelCenters of America LLC'>TA</a> <font color='green'>+3.0%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+2.3%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='green'>+2.2%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-4.3%</font>. <a href='https://seekingalpha.com/symbol/SMTC' title='Semtech Corporation'>SMTC</a> <font color='red'>-3.8%</font>. <a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='red'>-2.1%</font>. <a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a> <font color='red'>-2.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270849\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$PANW $BOX $TA - After Hours Gainers / Losers https://seekingalpha.com/news/3270849-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3270849-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270844\" data-ts=\"1496266269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMTC\" target=\"_blank\">SMTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270844-semtech-q1-beats-eps-misses-revenue-healthy-guidance-shares-down-3_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semtech Q1 beats EPS, misses revenue, healthy guidance; shares down 3.5%</a></h4><ul><li>Semtech's (NASDAQ:<a href='https://seekingalpha.com/symbol/SMTC' title='Semtech Corporation'>SMTC</a>) Q1 report beat EPS estimates but missed on revenue. Other key metrics include 60.9% gross margin, 26.6% operating margin, and over $50M split nearly evenly between SG&amp;A and R&amp;D expenses.</li><li>Q2 guidance includes revenue of $150M to $160M and $0.43 to $0.49 EPS. Consensus estimates put revenue at $152.23M and EPS at $0.44. Guidance also includes gross margin between 60.5% and 61.5% and tax rate between 19% and 23%.</li><li>Semtech shares are&nbsp;<font color='red'>down 3.5%</font>&nbsp;aftermarket.</li><li><a href=\"https://seekingalpha.com/pr/16848713-semtech-announces-first-quarter-fiscal-year-2018-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3270829-semtech-beats-0_03-misses-revenue\" target=\"_blank\">Semtech beats by $0.03, misses on revenue</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270844\" data-linked=\"Semtech Q1 beats EPS, misses revenue, healthy guidance; shares down 3.5%\" data-tweet=\"$SMTC - Semtech Q1 beats EPS, misses revenue, healthy guidance; shares down 3.5% https://seekingalpha.com/news/3270844-semtech-q1-beats-eps-misses-revenue-healthy-guidance-shares-down-3_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3270844-semtech-q1-beats-eps-misses-revenue-healthy-guidance-shares-down-3_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270838\" data-ts=\"1496265895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOX\" target=\"_blank\">BOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270838-box-q1-beats-estimates-guidance-healthy-shares-up-3_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Box Q1 beats estimates, guidance healthy; shares up 3.5%</a></h4><ul><li>Box's (NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a>) Q1 report beat EPS and revenue estimates. Billings were $99.6M, up 31% from the prior year&rsquo;s quarter. Other key metrics include $8.5M in cash from operating activities and $4M FCF.</li><li>Q2 guidance includes revenue between $121M and $122M, which barely straddles the consensus estimate of $121.28M, and a loss per share of $0.13 to $0.12 with the upper end in line with consensus.</li><li>FY18 guidance has revenue at $502M to $506M and a loss per share of $0.48 to $0.44. Consensus has revenue at $502.85M and loss per share at $0.46.</li><li>Box shares are&nbsp;<font color='green'>up 3.5%</font>&nbsp;aftermarket.</li><li><a href=\"https://seekingalpha.com/pr/16848636-box-reports-30-percent-revenue-growth-fiscal-first-quarter-2018\" target=\"_blank\">Press Release&nbsp;</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3270812-box-beats-0_01-beats-revenue\" target=\"_blank\">Box beats by $0.01, beats on revenue</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270838\" data-linked=\"Box Q1 beats estimates, guidance healthy; shares up 3.5%\" data-tweet=\"$BOX - Box Q1 beats estimates, guidance healthy; shares up 3.5% https://seekingalpha.com/news/3270838-box-q1-beats-estimates-guidance-healthy-shares-up-3_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3270838-box-q1-beats-estimates-guidance-healthy-shares-up-3_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270841\" data-ts=\"1496264552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NERV\" target=\"_blank\">NERV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270841-janssen-to-return-rights-to-minminus-202-to-minerva-after-j-and-js-actelion-deal-goes-through\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Janssen to return rights to MIN-202 to Minerva after J&amp;J&#39;s Actelion deal goes through; Minerva up 14% after hours</a></h4><ul><li>Johnson &amp; Johnson's pending acquisition of Actelion leads to a <a href=\"https://seekingalpha.com/pr/16848644-minerva-announces-amended-agreement-minminus-202-insomnia\" target=\"_blank\">restructuring</a> of the license and development agreement between Minerva Neurosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NERV' title='Minerva Neurosciences'>NERV</a>) and Janssen Pharmaceutica NV related to insomnia and MDD candidate MIN-202.</li><li>The companies have inked a binding term sheet revising the agreement, contingent on the closing of the Actelion transaction. Under the terms of the amended contract, Minerva will regain global control of the development of MIN-202 for insomnia and Janssen will give up its potential insomnia-related royalties in Minerva territories. Minerva retains its current rights to MIN-202 for the adjunctive treatment of major depressive disorder &#40;MDD&#41;.</li><li>Under the new deal, Minerva will receive an upfront payment of $30M, $20M at the start of a Phase 3 insomnia study and $20M when the study is 50% enrolled. Janssen will waive the remaining ~$13M due Minerva for Phase 2 development. Minerva will assume all costs for Phase 3 activities.</li><li>Minerva alll also repurchase the ~3.9M shares of its common stock owned by J&amp;J Innovation at par ($0.0001) or ~$389.</li><li>The company says it has sufficient resources to fund the development of MIN-202 and MIN-101 through 2019, enough time to generate top-line data from a Phase 3 study of MIN-101 and three Phase 2b trials for MIN-202 in both indications.</li><li>NERV is up&nbsp;<font color='green'>14%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270841\" data-linked=\"Janssen to return rights to MIN-202 to Minerva after J&amp;J&#39;s Actelion deal goes through; Minerva up 14% after hours\" data-tweet=\"$NERV - Janssen to return rights to MIN-202 to Minerva after J&amp;J&#39;s Actelion deal goes through; Minerva up 14% after hours https://seekingalpha.com/news/3270841-janssen-to-return-rights-to-minminus-202-to-minerva-after-j-and-js-actelion-deal-goes-through?source=tweet\" data-url=\"https://seekingalpha.com/news/3270841-janssen-to-return-rights-to-minminus-202-to-minerva-after-j-and-js-actelion-deal-goes-through\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270837\" data-ts=\"1496263986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270837-oil-bounces-after-bullish-storage-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil bounces after bullish storage report</a></h4><ul><li>The API reports a whopping 8.67M decline in U.S. crude stocks last week - it would be the largest draw in about nine months. Trade estimates for the EIA number tomorrow are for just a 3M barrel drop in stocks.</li><li>Crude had a rough regular session,&nbsp;<font color='red'>down nearly 3%</font>, but it's rising after hours. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>&nbsp;<font color='green'>+1.1%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3270837\" data-linked=\"Oil bounces after bullish storage report\" data-tweet=\"$USO $OIL $UCO - Oil bounces after bullish storage report https://seekingalpha.com/news/3270837-oil-bounces-after-bullish-storage-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3270837-oil-bounces-after-bullish-storage-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270833\" data-ts=\"1496263358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPE\" target=\"_blank\">HPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270833-hewlett-packard-enterprise-reports-in-line-q2-mixed-guidance-shares-down-2_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hewlett Packard Enterprise reports in-line Q2, mixed guidance; shares down 2.5%</a></h4><ul><li>Hewlett Packard Enterprise (NYSE:<a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a>) Q2 report matched consensus EPS estimates. Other key metrics include 7.8% operating margin and $600M cash flow from operations.</li><li>Q3 guidance puts EPS between $0.24 and $0.28, which comes in below the $0.31 consensus estimate.</li><li>FY 2017 guidance reiterated with EPS between $1.46 and $1.56, which has the low end one cent below the consensus estimate.</li><li>Shares&nbsp;<font color='red'>down 2.5%</font>&nbsp;aftermarket.</li><li><a href=\"https://seekingalpha.com/pr/16848642-hpe-reports-fiscal-2017-second-quarter-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3270811-hewlett-packard-enterprise-eps-line\" target=\"_blank\">Hewlett Packard Enterprise EPS in-line</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270833\" data-linked=\"Hewlett Packard Enterprise reports in-line Q2, mixed guidance; shares down 2.5%\" data-tweet=\"$HPE - Hewlett Packard Enterprise reports in-line Q2, mixed guidance; shares down 2.5% https://seekingalpha.com/news/3270833-hewlett-packard-enterprise-reports-in-line-q2-mixed-guidance-shares-down-2_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3270833-hewlett-packard-enterprise-reports-in-line-q2-mixed-guidance-shares-down-2_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270834\" data-ts=\"1496263226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSTG\" target=\"_blank\">NSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270834-nanostring-commences-equity-offering-shares-slip-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NanoString commences equity offering; shares slip 1% after hours</a></h4><ul><li>NanoString Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NSTG' title='NanoString Technologies'>NSTG</a>) inks an <a href=\"https://seekingalpha.com/pr/16848648-nanostring-technologies-announces-offering-common-stock\" target=\"_blank\">agreement </a>to sell 2.75M shares of common stock to underwriter Robert Baird &amp; Co. including a 30-day option to buy an additional 412.5K shares. Price and terms have yet to be announced. Net proceeds will fund working capital and general corporate purposes.</li><li>Shares are off&nbsp;<font color='red'>1%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270834\" data-linked=\"NanoString commences equity offering; shares slip 1% after hours\" data-tweet=\"$NSTG - NanoString commences equity offering; shares slip 1% after hours https://seekingalpha.com/news/3270834-nanostring-commences-equity-offering-shares-slip-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3270834-nanostring-commences-equity-offering-shares-slip-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270821\" data-ts=\"1496261994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270821-tesaro-exploring-sale-shares-up-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TESARO exploring sale; shares up 4% after hours</a></h4><ul><li>The WSJ <a href=\"https://www.wsj.com/articles/tesaro-explores-sale-1496260323\" target=\"_blank\">reports </a>that TESARO (NASDAQ:<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a>) has reached out to prospective bidders &nbsp;on a possible sale, which could reach $9B, but interest has been a bit tepid.</li><li>The FDA approved its cancer med ZEJULA (niraparib) in March. Analysts project it could generate peak sales of almost $2B by 2022 although competition from Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>) and AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a>) will be stiff.</li><li>Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) is one likely suitor considering its intent to expand its footprint in the cancer space.</li><li>TSRO is up&nbsp;<font color='green'>4%</font>&nbsp;after hours on robust volume. CLVS is down&nbsp;<font color='red'>2%</font>&nbsp;on light volume. AZN is up&nbsp;<font color='green'>1%</font>&nbsp;on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270821\" data-linked=\"TESARO exploring sale; shares up 4% after hours\" data-tweet=\"$TSRO $TSRO $CLVS - TESARO exploring sale; shares up 4% after hours https://seekingalpha.com/news/3270821-tesaro-exploring-sale-shares-up-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3270821-tesaro-exploring-sale-shares-up-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270820\" data-ts=\"1496261921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270820-palo-alto-networks-beats-estimates-issues-strong-guidance-shares-up-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks beats estimates, issues strong guidance; shares up 11%</a></h4><ul><li>Palo Alto Networks (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a>) Q3 report beat EPS and revenue estimates. Billings were $544.1M, up 12% from the prior year&rsquo;s quarter. Other key metrics include $211.2M cash from operations and $162.6M FCF.</li><li>Q4 guidance includes revenue between $481M and $491M, which straddles the consensus of $484.35M. Low end of EPS range of $0.78-$0.80 comes in $0.04 above consensus.</li><li>Palo Alto shares are&nbsp;<font color='green'>up nearly 11%</font>&nbsp;aftermarket.</li><li><a href=\"https://seekingalpha.com/pr/16848622-palo-alto-networks-reports-fiscal-third-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3270809-palo-alto-networks-beats-0_06-beats-revenue\" target=\"_blank\">Palo Alto Networks beats by $0.06, beats on revenue</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270820\" data-linked=\"Palo Alto Networks beats estimates, issues strong guidance; shares up 11%\" data-tweet=\"$PANW - Palo Alto Networks beats estimates, issues strong guidance; shares up 11% https://seekingalpha.com/news/3270820-palo-alto-networks-beats-estimates-issues-strong-guidance-shares-up-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3270820-palo-alto-networks-beats-estimates-issues-strong-guidance-shares-up-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270812\" data-ts=\"1496261504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOX\" target=\"_blank\">BOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270812-box-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Box beats by $0.01, beats on revenue</a></h4><ul><li>Box (NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a>): Q1 EPS of -$0.13 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $117M (+29.8% Y/Y) <font color='green'>beats by $2.26M</font>.</li><li>Shares <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/pr/16848636-box-reports-30-percent-revenue-growth-fiscal-first-quarter-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3270812\" data-linked=\"Box beats by $0.01, beats on revenue\" data-tweet=\"$BOX - Box beats by $0.01, beats on revenue https://seekingalpha.com/news/3270812-box-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3270812-box-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270810\" data-ts=\"1496261408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCOR\" target=\"_blank\">SCOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270810-comscore-expands-tv-measurement-through-bigger-deal-charter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ComScore expands TV measurement through bigger deal with Charter</a></h4><ul>   <li>ComScore (<a href=\"http://seekingalpha.com/symbol/SCOR\" target=\"_blank\">SCOR</a> <font color='green'>+1.3%</font>) has a new deal with Charter Communications (<a href=\"http://seekingalpha.com/symbol/CHTR\" target=\"_blank\">CHTR</a> <font color='green'>+2%</font>) <a href=\"https://seekingalpha.com/pr/16848542-comscore-expands-partnership-charter-communications\" target=\"_blank\">expanding its use</a> of Charter's TV viewing data.</li>    <li>Aggregated and anonymized data from Charter markets, including the Spectrum markets added through its takeovers of Time Warner Cable and Bright House Networks, will be integrated into comScore's measurement service, along with data from Charter's Spectrum TV Everywhere app.</li>    <li>The new markets mean comScore's passive measurement covers 35M homes and 75M television sets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270810\" data-linked=\"ComScore expands TV measurement through bigger deal with Charter\" data-tweet=\"$SCOR $SCOR $CHTR - ComScore expands TV measurement through bigger deal with Charter https://seekingalpha.com/news/3270810-comscore-expands-tv-measurement-through-bigger-deal-charter?source=tweet\" data-url=\"https://seekingalpha.com/news/3270810-comscore-expands-tv-measurement-through-bigger-deal-charter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270809\" data-ts=\"1496261150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270809-palo-alto-networks-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks beats by $0.06, beats on revenue</a></h4><ul><li>Palo Alto Networks (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a>): Q3 EPS of $0.61 <font color='green'>beats by $0.06</font>.</li><li>Revenue of $431.8M (+24.9% Y/Y) <font color='green'>beats by $19.88M</font>.</li><li>Shares <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/pr/16848622-palo-alto-networks-reports-fiscal-third-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3270809\" data-linked=\"Palo Alto Networks beats by $0.06, beats on revenue\" data-tweet=\"$PANW - Palo Alto Networks beats by $0.06, beats on revenue https://seekingalpha.com/news/3270809-palo-alto-networks-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3270809-palo-alto-networks-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270807\" data-ts=\"1496260653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSN\" target=\"_blank\">SSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270807-samson-oil-posts-record-daily-production-foreman-butte\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Samson Oil posts record daily production at Foreman Butte</a></h4><ul>     <li>Samson Oil and Gas (<a href='https://seekingalpha.com/symbol/SSN' title='Samson Oil & Gas Limited'>SSN</a> <font color='green'>+4.3%</font>) reports daily production at its Foreman Butte project <a href=\"https://seekingalpha.com/pr/16847239-samson-oil-and-gas-advisory\" target=\"_blank\">hit a record</a> 1,294 barrels on May 23, producing a gross operated rate for the company of 1K bbl/day, up from 720 bbl/day during March.</li>     <li>SSN attributes the recent increase to several factors, including pump optimization.</li>     <li>SSN also says it <a href=\"http://www.reuters.com/finance/stocks/SSN/key-developments/article/3603914\" target=\"_blank\">closed</a> on the sale of its state GC assets in New Mexico to a private U.S.-based energy company.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270807\" data-linked=\"Samson Oil posts record daily production at Foreman Butte\" data-tweet=\"$SSN - Samson Oil posts record daily production at Foreman Butte https://seekingalpha.com/news/3270807-samson-oil-posts-record-daily-production-foreman-butte?source=tweet\" data-url=\"https://seekingalpha.com/news/3270807-samson-oil-posts-record-daily-production-foreman-butte\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270803\" data-ts=\"1496259938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270803-arcelormittal-indias-sail-agree-on-proposal-to-advance-913m-venture\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal, India&#39;s SAIL agree on proposal to advance $913M venture</a></h4><ul>     <li>ArcelorMittal (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-2.3%</font>) and Steel Authority of India agree to a <a href=\"https://finance.yahoo.com/news/arcelormittal-sail-agree-mediators-proposal-140357731.html\" target=\"_blank\">proposal to export 20% of auto-grade steel</a> they aim to make under a <a href=\"https://seekingalpha.com/news/3269666-arcelormittal-agrees-concessions-delayed-897m-india-joint-venture\" target=\"_blank\">planned automotive joint venture</a>, Reuters reports.</li>     <li>MT also agrees to waive a fee for the venture to use its brand and its research and technology, that any losses caused by delays in setting up the partnership would be borne by the venture, and that the $913M cost to establish the venture could rise, according to the report.</li>     <li>Indian government think-tank NITI Aayog is mediating talks on commercial terms for the delayed venture that will give MT a foothold in the world's fastest growing steel market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270803\" data-linked=\"ArcelorMittal, India&#39;s SAIL agree on proposal to advance $913M venture\" data-tweet=\"$MT - ArcelorMittal, India&#39;s SAIL agree on proposal to advance $913M venture https://seekingalpha.com/news/3270803-arcelormittal-indias-sail-agree-on-proposal-to-advance-913m-venture?source=tweet\" data-url=\"https://seekingalpha.com/news/3270803-arcelormittal-indias-sail-agree-on-proposal-to-advance-913m-venture\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270799\" data-ts=\"1496259468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270799-taxpayers-overpaid-1_3b-for-epipen-800m-mylan-claimed-shares-ease-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taxpayers overpaid $1.3B for EpiPen, $800M more than Mylan claimed; shares ease 1%</a></h4><ul><li>Mylan N.V. (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='red'>-1%</font>) slips on below average volume on the heels of an <a href=\"https://www.grassley.senate.gov/news/news-releases/grassley-latest-estimate-taxpayers-overpaid-127-billion-epipen#.WS8Rq7wDOVo.twitter\" target=\"_blank\">announcement </a>from Senator Chuck Grassley's (R-Iowa) office that an HHS estimate showed taxpayers overpaid by as much as $1.27B for EpiPen from 2006 through 2016, $805M more than the company reported during settlement talks with the Department of Justice. The nature of the overcharges was a misclassification of the product under the Medicaid Drug Rebate Program.</li><li>Senator Grassley has requested a full accounting of the matter for months. The Centers for Medicare and Medicaid Services &#40;CMS&#41; provided records that confirmed that CMS notified Mylan on several occasions that EpiPen was misclassified, but the company took no action. Mylan has repeatedly refused to provide its records of communications with CMS to the Senate Judiciary Committee. A subpoena is the next step, a real possibility.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3226263-mylan-will-show-senate-hearing\" target=\"_blank\">Mylan will be a no-show at Senate hearing</a> (Nov. 22, 2016)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3226163-senator-grassley-says-mylan-bit-top-epipen-settlement-press-release\" target=\"_blank\">Senator Grassley says Mylan a bit over the top with EpiPen settlement press release</a> (Nov. 21, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270799\" data-linked=\"Taxpayers overpaid $1.3B for EpiPen, $800M more than Mylan claimed; shares ease 1%\" data-tweet=\"$MYL - Taxpayers overpaid $1.3B for EpiPen, $800M more than Mylan claimed; shares ease 1% https://seekingalpha.com/news/3270799-taxpayers-overpaid-1_3b-for-epipen-800m-mylan-claimed-shares-ease-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3270799-taxpayers-overpaid-1_3b-for-epipen-800m-mylan-claimed-shares-ease-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270798\" data-ts=\"1496259075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOSBF\" target=\"_blank\">TOSBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270798-toshiba-keeps-portion-of-chip-unit-to-remove-western-digital-hurdle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toshiba keeps portion of chip unit to remove Western Digital hurdle</a></h4><ul><li>Toshiba (<a href='https://seekingalpha.com/symbol/TOSBF' title='Toshiba Corp.'>OTCPK:TOSBF</a>, <a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>) will <a href=\"https://www.wsj.com/articles/toshiba-makes-legal-concession-on-sale-of-memory-chip-unit-1496239072?mod=e2twd\" target=\"_blank\">keep</a> some of its chip unit in-house while continuing to seek a buyer for the rest. The move is meant to waylay Western Digital&rsquo;s (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) attempted block of the chip unit sale, which could net Toshiba $20B.</li><li>Western Digital gained a stake in the chip unit following last year&rsquo;s purchase of SanDisk and had said that Toshiba doesn&rsquo;t have the right to sell the unit without approval. Toshiba disagrees and now plans to keep any chips that could fall under a rights claim by Western Digital.</li><li>Potential chip unit buyers include Sharp with parent company Foxconn and Broadcom Limited.</li><li>Toshiba shares are&nbsp;<font color='red'>down 7.8%</font>.</li><li>Western Digital shares are&nbsp;<font color='red'>d</font>own over 1%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3267120-western-digital-takes-toshiba-arbitration\" target=\"_blank\">Western Digital takes Toshiba to arbitration</a> (May 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270798\" data-linked=\"Toshiba keeps portion of chip unit to remove Western Digital hurdle\" data-tweet=\"$TOSBF $TOSBF $TOSYY - Toshiba keeps portion of chip unit to remove Western Digital hurdle https://seekingalpha.com/news/3270798-toshiba-keeps-portion-of-chip-unit-to-remove-western-digital-hurdle?source=tweet\" data-url=\"https://seekingalpha.com/news/3270798-toshiba-keeps-portion-of-chip-unit-to-remove-western-digital-hurdle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270800\" data-ts=\"1496258610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270800-solar-coal-companies-fall-on-reports-trump-may-dump-paris-climate-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solar, coal companies both fall on reports Trump may dump Paris climate deal</a></h4><ul>     <li>Solar stocks (<a href='https://seekingalpha.com/symbol/TAN' title='Invesco Solar Portfolio ETF'>TAN</a> <font color='red'>-0.5%</font>) are broadly lower following <a href=\"https://seekingalpha.com/news/3270660-report-trump-pull-u-s-paris-climate-deal\" target=\"_blank\">reports</a> that Pres. Trump has decided to pull out of Paris climate deal, which aimed to cut carbon emissions around the world with a larger focus on renewable forms of energy.</li>     <li>With less than an hour of trading left: <a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color='red'>-2.5%</font>, <a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color='red'>-3.3%</font>, <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='red'>-5.7%</font>, <a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='red'>-5.9%</font>, <a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a> <font color='red'>-3.8%</font>, <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a> <font color='red'>-4.9%</font>, <a href='https://seekingalpha.com/symbol/SOL' title='ReneSola Ltd.'>SOL</a> <font color='red'>-2.9%</font>.</li>     <li>But coal companies (<a href='https://seekingalpha.com/symbol/KOL' title='VanEck Vectors Coal ETF'>KOL</a> <font color='red'>-1.2%</font>) also are lower, perhaps reflecting concerns raised by some coal companies that a U.S. exit from the Paris agreement <a href=\"http://www.reuters.com/article/us-usa-climatechange-winners-idUSKBN18R2BO\" target=\"_blank\">could unleash a global backlash</a> against U.S. coal interests.</li>     <li>Peabody Energy (<a href='https://seekingalpha.com/symbol/BTU' title='Peabody Energy Corp.'>BTU</a> <font color='red'>-3.2%</font>) says it would support a decision to withdraw from the Paris accord because the \"accord is flawed on a number of levels,\" but it had argued that Trump should stay in the deal to help protect coal industry interests overseas.</li>     <li>Cloud Peak Energy (<a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy, Inc.'>CLD</a> <font color='red'>-1.8%</font>) also had argued to stay in the Paris deal to prevent other nations from an aggressive turn against the global coal industry.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270800\" data-linked=\"Solar, coal companies both fall on reports Trump may dump Paris climate deal\" data-tweet=\"$FSLR $TAN $FSLR - Solar, coal companies both fall on reports Trump may dump Paris climate deal https://seekingalpha.com/news/3270800-solar-coal-companies-fall-on-reports-trump-may-dump-paris-climate-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3270800-solar-coal-companies-fall-on-reports-trump-may-dump-paris-climate-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>155&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270791\" data-ts=\"1496257567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MACK\" target=\"_blank\">MACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270791-merrimack-in-free-fall-after-cfo-departure-and-140m-dividend-shares-down-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merrimack in free fall after CFO departure and $140M dividend; shares down 24%</a></h4><ul><li>Micro cap Merrimack Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='red'>-23.9%</font>) is getting roughed up today on almost a 5x surge in volume as investors sell shares after receiving the <a href=\"http://investors.merrimack.com/releasedetail.cfm?releaseid=1020338\" target=\"_blank\">$140M special dividend</a> on May 26 from the asset sale to Ipsen.</li><li>The May 25 announcement that CFO Dr. Yasir Al-Wakeel will resign on June 9 added extra fuel to the fire. Shares are down 33% since May 17, the ex-d date for the dividend.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3255176-ipsen-completes-purchase-merrimack-assets-mack-4-percent\" target=\"_blank\">Ipsen completes purchase of Merrimack assets; MACK up 4%</a> (April 3)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270054-merrimack-finance-chief-bids-adieu\" target=\"_blank\">Merrimack finance chief bids adieu</a> (May 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270791\" data-linked=\"Merrimack in free fall after CFO departure and $140M dividend; shares down 24%\" data-tweet=\"$MACK - Merrimack in free fall after CFO departure and $140M dividend; shares down 24% https://seekingalpha.com/news/3270791-merrimack-in-free-fall-after-cfo-departure-and-140m-dividend-shares-down-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3270791-merrimack-in-free-fall-after-cfo-departure-and-140m-dividend-shares-down-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270787\" data-ts=\"1496256485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGR\" target=\"_blank\">AVGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270787-avingers-pantheris-shows-long-term-treatment-benefit-in-atherectomy-shares-up-26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avinger&#39;s Pantheris shows long-term treatment benefit in atherectomy; shares up 26%</a></h4><ul><li>Nano cap Avinger (<a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+25.7%</font>) heads north on a 7x surge in volume in response to <a href=\"https://seekingalpha.com/pr/16848344-avinger-announces-verified-data-24-month-outcomes-pivotal-vision-study-lumivascular\" target=\"_blank\">positive 24-month data</a> from the VISION study assessing the safety and effectiveness of its Pantheris system in performing directional atherectomy while allowing the physician to use real-time intravascular imaging to aid in the removal of plaque from leg arteries.</li><li>Follow-up on 89 patients showed showed 82% freedom from target lesion revascularization &#40;TLR&#41; at month 12 by patient (84% by lesion) and 74% freedom from TLR at month 24 by patient (76% by lesion).</li><li>Only 9.6% (n=19/198) of lesions required adjunctive drug-coated balloon therapy and only 5% (n=10/198) needed adjunctive stent therapy.</li><li>Data from VISION supported the FDA's 510(k) clearance of the device in March 2016.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3237870-positive-lumivascular-trial-data-stokes-avinger-shares-ahead-35-percent-premarket\" target=\"_blank\">Positive Lumivascular trial data stokes Avinger; shares ahead 35% premarket</a> (Jan. 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3154446-fda-clears-enhanced-version-avingers-pantheris-system\" target=\"_blank\">FDA clears enhanced version of Avinger's Pantheris system</a> (March 1, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270787\" data-linked=\"Avinger&#39;s Pantheris shows long-term treatment benefit in atherectomy; shares up 26%\" data-tweet=\"$AVGR - Avinger&#39;s Pantheris shows long-term treatment benefit in atherectomy; shares up 26% https://seekingalpha.com/news/3270787-avingers-pantheris-shows-long-term-treatment-benefit-in-atherectomy-shares-up-26?source=tweet\" data-url=\"https://seekingalpha.com/news/3270787-avingers-pantheris-shows-long-term-treatment-benefit-in-atherectomy-shares-up-26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270786\" data-ts=\"1496255450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270786-technology-top-gainers-losers-of-2-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:30 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/MRAM' title='Everspin Technologies'>MRAM</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a> <font color='red'>-6%</font>. NQ <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/TRT' title='Trio-Tech International'>TRT</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270786\" data-linked=\"Technology - Top Gainers / Losers as of 2:30 pm\" data-tweet=\"$SPI $MRAM $QBAK - Technology - Top Gainers / Losers as of 2:30 pm https://seekingalpha.com/news/3270786-technology-top-gainers-losers-of-2-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3270786-technology-top-gainers-losers-of-2-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270785\" data-ts=\"1496255243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270785-microbot-nabs-canadian-patent-protecting-self-cleaning-shunt-shares-ahead-27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microbot nabs Canadian patent protecting self-cleaning shunt; shares ahead 27%</a></h4><ul><li>Thinly traded nano cap Microbot Medical (<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a> <font color='green'>+26.8%</font>) jumps on a 7x surge in volume, albeit on turnover of only 344K shares, in response to its <a href=\"https://seekingalpha.com/pr/16847491-microbot-medical-inc-announces-issuance-canadian-patent-covering-self-cleaning-shunt\" target=\"_blank\">announcement </a>that the Canadian Intellectual Property Office has issued patent No. 2,803,0462 covering its Self-Cleaning Shunt, specifically an inlet head for use on shunts.</li><li>The company has an exclusive license to the patent from the Technion - Israel Institute of Technology.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270785\" data-linked=\"Microbot nabs Canadian patent protecting self-cleaning shunt; shares ahead 27%\" data-tweet=\"$MBOT - Microbot nabs Canadian patent protecting self-cleaning shunt; shares ahead 27% https://seekingalpha.com/news/3270785-microbot-nabs-canadian-patent-protecting-self-cleaning-shunt-shares-ahead-27?source=tweet\" data-url=\"https://seekingalpha.com/news/3270785-microbot-nabs-canadian-patent-protecting-self-cleaning-shunt-shares-ahead-27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270779\" data-ts=\"1496253929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PF\" target=\"_blank\">PF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270779-pinnacle-foods-volatile-on-conference-cancellation-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinnacle Foods volatile on conference cancellation chatter</a></h4><ul><li>Pinnacle Foods (<a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a> <font color='green'>+2%</font>) trades higher on elevated volume amid trader talk that the company pulled out of a Deutsche Bank consumer conference scheduled for the middle part of June.</li><li>The food company isn't commenting on the scuttlebutt.</li><li>Shares of Pinnacle raced to a 52-week of $64.00 before settling back.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270779\" data-linked=\"Pinnacle Foods volatile on conference cancellation chatter\" data-tweet=\"$PF - Pinnacle Foods volatile on conference cancellation chatter https://seekingalpha.com/news/3270779-pinnacle-foods-volatile-on-conference-cancellation-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3270779-pinnacle-foods-volatile-on-conference-cancellation-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270778\" data-ts=\"1496253709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270778-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/MTL' title='Mechel OAO'>MTL</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='red'>-31%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270778\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$CRK $MTL $AKG - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3270778-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3270778-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270770\" data-ts=\"1496250705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBIO\" target=\"_blank\">CBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270770-european-advisory-group-backs-orphan-drug-tag-for-catalyst-bios-hemophilia-b-candidate-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs Orphan Drug tag for Catalyst Bio&#39;s hemophilia B candidate; shares ahead 17%</a></h4><ul><li>The European Medicines Agency's Committee for Orphan Medicinal Products &#40;COMP&#41; <a href=\"https://seekingalpha.com/pr/16847627-catalyst-biosciences-factor-ix-recommended-orphan-drug-designation-europe\" target=\"_blank\">adopts </a>a positive opinion supporting an Orphan Drug designation for Catalyst Biosciences' (<a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='green'>+16.5%</font>) CB-2679d/ISU304, a next-generation coagulation Factor IX variant, for the treatment of hemophilia B.</li><li>The company's South Korean collaborator, ISU Abxis, intends to launch a Phase 1/2 proof-of-concept study in people with severe hemophilia B next month.</li><li>Among the benefits of Orphan Drug status in the EU is a 10-year period of market exclusivity for the indication, if approved.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270770\" data-linked=\"European advisory group backs Orphan Drug tag for Catalyst Bio&#39;s hemophilia B candidate; shares ahead 17%\" data-tweet=\"$CBIO - European advisory group backs Orphan Drug tag for Catalyst Bio&#39;s hemophilia B candidate; shares ahead 17% https://seekingalpha.com/news/3270770-european-advisory-group-backs-orphan-drug-tag-for-catalyst-bios-hemophilia-b-candidate-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3270770-european-advisory-group-backs-orphan-drug-tag-for-catalyst-bios-hemophilia-b-candidate-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270767\" data-ts=\"1496250146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270767-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MVC' title='MVC Capital'>MVC</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EQS' title='Equus Total Return'>EQS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/TRCB' title='Two River Bancorp'>TRCB</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MFIN' title='Medallion Financial'>MFIN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/JRVR' title='James River Group Holdings'>JRVR</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270767\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$MVC $EQS $TRCB - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3270767-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3270767-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270765\" data-ts=\"1496249317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMPRF\" target=\"_blank\">LMPRF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270765-saudi-aramco-unveils-5_2b-persian-gulf-shipyard-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Saudi Aramco unveils $5.2B Persian Gulf shipyard project</a></h4><ul>     <li>Saudi Aramco announces plans to <a href=\"http://www.reuters.com/article/us-aramco-shipbuilding-hyundai-heavy-lam-idUSKBN18R0MP\" target=\"_blank\">build the Persian Gulf's largest shipyard</a> through a joint venture with three companies, including London-listed Lamprell (<a href='https://seekingalpha.com/symbol/LMPRF' title='Lamprell PLC'>OTCPK:LMPRF</a>), which <a href=\"https://www.bloomberg.com/news/articles/2017-05-31/saudi-arabia-s-5-2-billion-maritime-project-boosts-lamprell\" target=\"_blank\">surged the most in two years</a> before settling for a 5.7% advance.</li>     <li>The $5.2B JV aimed at helping reduce the Saudi economy's reliance on oil also includes National Shipping Co of Saudi Arabia, a state-controlled firm which ships oil for Aramco, and South Korea's Hyundai Heavy Industries.</li>     <li>Aramco says the maritime yard will be able to work on four offshore rigs and more than 40 vessels per year including three VLCCs; major production is expected to start in 2019, with the yard hitting full capacity by 2022.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270765\" data-linked=\"Saudi Aramco unveils $5.2B Persian Gulf shipyard project\" data-tweet=\"$LMPRF - Saudi Aramco unveils $5.2B Persian Gulf shipyard project https://seekingalpha.com/news/3270765-saudi-aramco-unveils-5_2b-persian-gulf-shipyard-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3270765-saudi-aramco-unveils-5_2b-persian-gulf-shipyard-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270763\" data-ts=\"1496248887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270763-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a> <font color='green'>+64%</font>. <a href='https://seekingalpha.com/symbol/EDUC' title='Educational Development Corporation'>EDUC</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/NDRM' title='NeuroDerm'>NDRM</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MRAM' title='Everspin Technologies'>MRAM</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/FENX' title='Fenix Parts'>OTC:FENX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CMCO' title='Columbus McKinnon Corporation'>CMCO</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/JILL' title='J. Jill Group, Inc.'>JILL</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='red'>-31%</font>. <a href='https://seekingalpha.com/symbol/OMNT' title='Ominto, Inc.'>OTCPK:OMNT</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/EQS' title='Equus Total Return'>EQS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/BUR' title='Burcon NutraScience Corp.'>BUR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ONS-OLD' title='Oncobiologics'>ONS-OLD</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MTNB' title='Matinas Biopharma Holdings, Inc.'>MTNB</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270763\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$EDUC $CBIO $NDRM - Midday Gainers / Losers https://seekingalpha.com/news/3270763-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3270763-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270759\" data-ts=\"1496246397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270759-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FENX' title='Fenix Parts'>OTC:FENX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/BORN' title='China New Borun Corporation'>BORN</a> <font color='red'>-10%</font>. KORS <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/STLY' title='HG Holdings Inc'>STLY</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270759\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FENX $VRA $WKHS - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3270759-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3270759-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270755\" data-ts=\"1496246002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABRTY\" target=\"_blank\">ABRTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270755-american-tower-crown-castle-linked-to-chatter-of-buying-cellnex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Tower, Crown Castle linked to chatter of buying Cellnex</a></h4><ul>   <li>Communications-tower spin-off Cellnex (<a href=\"http://seekingalpha.com/symbol/CLNXF\" target=\"_blank\">CLNXF</a> <font color='green'>+3.5%</font>) is <font color='green'>up 4.2%</font> in Madrid amid chatter that various companies may be <a href=\"http://www.reuters.com/article/us-cellnex-m-a-americantowers-idUSKBN18R0UD?feedType=nl&amp;feedName=innovationNews&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=US%20Deals%20Today%202017-05-31&amp;utm_term=US%20Deals%20Today\" target=\"_blank\">interested in buying</a>, though Abertis (<a href='https://seekingalpha.com/symbol/ABRTY' title='Abertis Infraestructuras SA ADR'>OTCPK:ABRTY</a>) says it hasn't gotten an offer for its stake.</li>    <li>Aside from American Tower (<a href=\"http://seekingalpha.com/symbol/AMT\" target=\"_blank\">AMT</a> <font color='green'>+0.1%</font>) exploring an opportunity to expand in Europe, Crown Castle (<a href=\"http://seekingalpha.com/symbol/CCI\" target=\"_blank\">CCI</a> <font color='red'>-0.8%</font>) is a possible buyer, according to the <i>Expansion</i> newspaper.</li>    <li>Cellnex says it hasn't had any contact with American Tower, though, and such a bid would be dependent on a merger between Abertis and Italy's Atlantia, Bloomberg says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270755\" data-linked=\"American Tower, Crown Castle linked to chatter of buying Cellnex\" data-tweet=\"$ABRTY $ABRTY $CLNXF - American Tower, Crown Castle linked to chatter of buying Cellnex https://seekingalpha.com/news/3270755-american-tower-crown-castle-linked-to-chatter-of-buying-cellnex?source=tweet\" data-url=\"https://seekingalpha.com/news/3270755-american-tower-crown-castle-linked-to-chatter-of-buying-cellnex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270754\" data-ts=\"1496246000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELEEF\" target=\"_blank\">ELEEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270754-canadas-element-fleet-plunges-bounces\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canada&#39;s Element Fleet plunges, then bounces</a></h4><ul><li>Element Fleet Management&nbsp;<font color='red'>plunged nearly 40%</font>&nbsp;in early action in Toronto this morning (before being halted), prompting the company to say it's unaware of any reason for the decline or massive trading volume.</li><li>One rumor had Muddy Waters as short the name, but Muddy Waters has denied that.</li><li>Shares have resumed trade, now&nbsp;<font color='red'>down 10.9%</font>&nbsp;on the session. They trade here under <a href='https://seekingalpha.com/symbol/ELEEF' title='Element Fleet Mgmt Corp.'>OTC:ELEEF</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270754\" data-linked=\"Canada&#39;s Element Fleet plunges, then bounces\" data-tweet=\"$ELEEF - Canada&#39;s Element Fleet plunges, then bounces https://seekingalpha.com/news/3270754-canadas-element-fleet-plunges-bounces?source=tweet\" data-url=\"https://seekingalpha.com/news/3270754-canadas-element-fleet-plunges-bounces\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270746\" data-ts=\"1496244233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDOC\" target=\"_blank\">TDOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270746-cowen-bullish-on-teladoc-sees-20-on-potential-expanded-market-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen bullish on Teladoc; sees 20% on potential expanded market; shares ahead 2%</a></h4><ul><li>Cowen's Charles Rhyee says a telemedicine access bill recently <a href=\"https://healthtechmagazine.net/article/2017/05/new-bill-looks-expand-telemedicine-access\" target=\"_blank\">reintroduced</a> by six U.S. senators <a href=\"https://www.streetinsider.com/Analyst+Comments/Teladoc+%28TDOC%29+PT+Raised+to+%2436+at+Cowen%3B+Telemedicine+Access+Bill+Could+Expand+Industry+TAM+Addl+%242.5B/12960752.html\" target=\"_blank\">bodes well</a> for Teladoc (<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a> <font color='green'>+2.4%</font>) because it would expand the company's available market by $2.5B. He adds that the bill would initiate a five-year telehealth study in Massachusetts and allows a telehealth approach in home dialysis (OUTPERFORM/$36).</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3270746\" data-linked=\"Cowen bullish on Teladoc; sees 20% on potential expanded market; shares ahead 2%\" data-tweet=\"$TDOC - Cowen bullish on Teladoc; sees 20% on potential expanded market; shares ahead 2% https://seekingalpha.com/news/3270746-cowen-bullish-on-teladoc-sees-20-on-potential-expanded-market-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3270746-cowen-bullish-on-teladoc-sees-20-on-potential-expanded-market-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270745\" data-ts=\"1496243887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRI\" target=\"_blank\">CPRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270745-michael-kors-to-closeplus-100-stores\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Michael Kors to close +100 stores</a></h4><ul>     <li>Michael Kors (KORS) plans to close between 100 and 125 stores over the next two years in an effort to improve profitability.</li><li>The strategy indicates that the issues for the company go beyond the department store channel.</li>     <li>Shares of MK are&nbsp;<font color='red'>down 9.38%&nbsp;</font>on the day, while peers Fossil (<a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='red'>-4%</font>) and Movado (<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='red'>-1.4%</font>) are also tilting lower.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270638-michael-kors-holdings-beats-0_03-beats-revenue\" target=\"_blank\">Michael Kors Holdings beats by $0.03, beats on revenue</a> (May 31)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270650-soft-guidance-sends-michael-kors-spiraling\" target=\"_blank\">Soft guidance sends Michael Kors spiraling</a> (May 31)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270745\" data-linked=\"Michael Kors to close +100 stores\" data-tweet=\"$CPRI $CPRI $FOSL - Michael Kors to close +100 stores https://seekingalpha.com/news/3270745-michael-kors-to-closeplus-100-stores?source=tweet\" data-url=\"https://seekingalpha.com/news/3270745-michael-kors-to-closeplus-100-stores\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270724\" data-ts=\"1496242867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270724-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MLSS' title='Milestone Scientific Inc.'>MLSS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/NDRM' title='NeuroDerm'>NDRM</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/ONS-OLD' title='Oncobiologics'>ONS-OLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MTNB' title='Matinas Biopharma Holdings, Inc.'>MTNB</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270724\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$CBIO $HLTH $MLSS - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3270724-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3270724-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270739\" data-ts=\"1496242110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEIP\" target=\"_blank\">MEIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270739-mei-pharmas-blood-cancer-candidate-meminus-401-performs-well-in-early-stage-study-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MEI Pharma&#39;s blood cancer candidate ME-401 performs well in early-stage study; shares up 4%</a></h4><ul><li>Thinly traded nano cap MEI Pharma (<a href='https://seekingalpha.com/symbol/MEIP' title='MEI Pharma, Inc.'>MEIP</a> <font color='green'>+3.8%</font>) heads north on a 4x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16847692-mei-pharma-announces-pre-specified-response-rate-exceeded-dose-escalation-studyminus-401\" target=\"_blank\">announcement </a>of positive results from an open-label, dose-escalation Phase 1b study assessing PI3K delta inhibitor ME-401 in relapsed/refractory chronic lymphocytic leukemia &#40;CLL&#41; and follicular lymphoma &#40;FL&#41;.</li><li>Six patients have been on study for at least 10 weeks. No reports of elevated liver enzymes, colitis or pneumonitis have been reported. One patient experienced grade 3 (serious) neutropenia. All other adverse events were grades 1 or 2. There were no discontinuations.</li><li>Per a review of the safety and efficacy data, the Safety Review Committee determined a minimum biologically effective dose (mBED) for ME-401 at 60 mg to start which can be escalated to 120 mg. The mBED is the dose that achieves a response in at least three of the six patients.</li><li>Complete data will be submitted for presentation at a future scientific conference.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270739\" data-linked=\"MEI Pharma&#39;s blood cancer candidate ME-401 performs well in early-stage study; shares up 4%\" data-tweet=\"$MEIP - MEI Pharma&#39;s blood cancer candidate ME-401 performs well in early-stage study; shares up 4% https://seekingalpha.com/news/3270739-mei-pharmas-blood-cancer-candidate-meminus-401-performs-well-in-early-stage-study-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3270739-mei-pharmas-blood-cancer-candidate-meminus-401-performs-well-in-early-stage-study-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270737\" data-ts=\"1496241354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXRX-OLD\" target=\"_blank\">CXRX-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270737-uk-competition-watchdog-to-continue-investigation-concordia-pricing-shares-slip-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UK competition watchdog to continue investigation into Concordia pricing; shares slip 4%</a></h4><ul><li>The UK's Competition and Markets Authority &#40;CMA&#41; has <a href=\"https://seekingalpha.com/pr/16847514-concordia-international-corp-announces-results-first-cma-stop-go-decision\" target=\"_blank\">notified </a>Concordia International (<a href='https://seekingalpha.com/symbol/CXRX-OLD' title='Concordia International Corp'>CXRX-OLD</a> <font color='red'>-3.5%</font>) that it will continue its investigation into a potential violation of competition law, specifically the pricing of its 10 mg hydrocortisone between 2013 and 2016. The potential breach pertains to a supply agreement involving Amdipharm which the company bought in 2015.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248508-uk-competition-watchdog-says-concordia-actavis-may-colluded-drug-prices\" target=\"_blank\">UK competition watchdog says Concordia and Actavis may have colluded on drug prices</a> (March 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270737\" data-linked=\"UK competition watchdog to continue investigation into Concordia pricing; shares slip 4%\" data-tweet=\"$CXRX-OLD - UK competition watchdog to continue investigation into Concordia pricing; shares slip 4% https://seekingalpha.com/news/3270737-uk-competition-watchdog-to-continue-investigation-concordia-pricing-shares-slip-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3270737-uk-competition-watchdog-to-continue-investigation-concordia-pricing-shares-slip-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270735\" data-ts=\"1496241172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270735-movie-slump-amc-and-imax-fall-to-52-week-lows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Movie slump: AMC and IMAX fall to 52-week lows</a></h4><ul> <li>AMC Entertainment (<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a> <font color='red'>-3.2%</font>) and IMAX (<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a> <font color='red'>-4.5%</font>) are notably lower again as investors continue to react to the weak Memorial Day weekend box office haul in the U.S. and assess the forecasts for growth in China.</li> <li>Both stocks hit their 52-week low in the last 20 minutes.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270476-movie-traffic-disappoints-holiday-weekend\" target=\"_blank\">Movie traffic disappoints over holiday weekend</a> (May 30)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270598-holiday-movies-push-disney-past-1b-domestic-box-2017\" target=\"_blank\">Holiday movies push Disney past $1B domestic box for 2017</a> (May 30)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3270735\" data-linked=\"Movie slump: AMC and IMAX fall to 52-week lows\" data-tweet=\"$AMC $AMC $IMAX - Movie slump: AMC and IMAX fall to 52-week lows https://seekingalpha.com/news/3270735-movie-slump-amc-and-imax-fall-to-52-week-lows?source=tweet\" data-url=\"https://seekingalpha.com/news/3270735-movie-slump-amc-and-imax-fall-to-52-week-lows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270734\" data-ts=\"1496240968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270734-modest-gains-for-treasurys-after-soft-economic-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Modest gains for Treasurys after soft economic data</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3270728-pending-home-sales-drop\" target=\"_blank\">Pending home sales</a> unexpectedly fell 1.3% in April, according to the NAR (expectations had been for a modest increase). It's the 2nd consecutive monthly decline. On a year-over-year basis, sales were down 3.3% - the largest Y/Y decline in nearly three years.</li><li>At issue, according to the NAR</a>, is declining affordability thanks to low supply, and fast appreciation in home values.</li><li>Meanwhile, the <a href=\"https://seekingalpha.com/news/3270718-chicago-pmi\" target=\"_blank\">Chicago PMI for May</a> fell a more-than-expected 3.1 points to 55.2.</li><li>Today also sees another central banker acknowledging the <a href=\"https://seekingalpha.com/news/3270659-fixed-income-closing-another-strong-month\" target=\"_blank\">recent unexpected decline</a> in inflation. Dallas Fed President Robert Kaplan is \"concerned,\" but it's not yet enough for him to change his rate hike views.</li><li>The 10-year Treasury yield is down about one basis point to 2.20%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.2</font>%, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a><font color='red'> -0.4%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares UltraPro Short 20+ Year Treasury ETF'>TTT</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Government Bond Index ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Ultra 20+ Year Treasury ETF'>UBT</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath U.S. Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/TLO' title='SPDR Barclays Long Term Treasury ETF'>TLO</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/DLBL' title='iPath U.S. Treasury Long Bond Bull ETN'>DLBL</a>, <a href='https://seekingalpha.com/symbol/TYBS' title='Direxion Daily 20+ Year Treasury Bear 1x Shares ETF'>TYBS</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3270734\" data-linked=\"Modest gains for Treasurys after soft economic data\" data-tweet=\"$TLT $TBT $TMV - Modest gains for Treasurys after soft economic data https://seekingalpha.com/news/3270734-modest-gains-for-treasurys-after-soft-economic-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3270734-modest-gains-for-treasurys-after-soft-economic-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270733\" data-ts=\"1496240732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKG\" target=\"_blank\">AKG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270733-asanko-goldminus-15-muddy-waters-says-is-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asanko Gold -15% as Muddy Waters says it is short</a></h4><ul><li>Asanko Gold (<a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='red'>-15%</font>) plunges to 52-week lows as Muddy Waters says it is short the stock, believing it is \"<a href=\"http://www.muddywatersresearch.com/research/akg/mw-is-short-asanko/\" target=\"_blank\">highly likely to end up a Zero</a>.\"</li><li>A new Muddy Waters report says AKG made investments based on flawed geology in Nkran, its  satellite pits and Esaase that it believes \"will never be recovered.\"</li><li>The report also claims some of AKG&rsquo;s resource models have been  &ldquo;smeared,\" which would cause estimates of ore contents to be  inflated.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270733\" data-linked=\"Asanko Gold -15% as Muddy Waters says it is short\" data-tweet=\"$AKG - Asanko Gold -15% as Muddy Waters says it is short https://seekingalpha.com/news/3270733-asanko-goldminus-15-muddy-waters-says-is-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3270733-asanko-goldminus-15-muddy-waters-says-is-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270732\" data-ts=\"1496240707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSLS\" target=\"_blank\">RSLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270732-enteromedics-announces-first-vbloc-implant-illinois-hospital-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnteroMedics announces first vBloc implant at Illinois hospital; shares up 3%</a></h4><ul><li>Nano cap EnteroMedics (ETRM <font color='green'>+3.2%</font>) perks up on almost double normal volume in response to its <a href=\"https://seekingalpha.com/pr/16847412-enteromedics-announces-first-vbloc-neurometabolic-therapy-implant-amita-health-adventist\" target=\"_blank\">announcement </a>of the first vBloc implant at AMITA Health Adventist Medical Center in Bolingbrook, IL.</li><li>The company's vBloc is&nbsp;a pacemaker-like device that delivers vagal nerve blocking therapy via electrodes that are surgically implanted subcutaneously in the abdomen. The electrodes are placed in contact with the trunks of the vagus nerves just above the junction between the esophagus and the stomach. The device intermittently blocks vagal nerve signals throughout the patient's waking hours which produces the sensation of fullness.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270732\" data-linked=\"EnteroMedics announces first vBloc implant at Illinois hospital; shares up 3%\" data-tweet=\"$RSLS - EnteroMedics announces first vBloc implant at Illinois hospital; shares up 3% https://seekingalpha.com/news/3270732-enteromedics-announces-first-vbloc-implant-illinois-hospital-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3270732-enteromedics-announces-first-vbloc-implant-illinois-hospital-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270731\" data-ts=\"1496240517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270731-volatility-on-skechers-picks-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatility on Skechers picks up</a></h4><ul> <li>Skechers (<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+3.2%</font>) shoots higher amid some trader chatter on a buyout.</li> <li>Over 1.11M shares of Skechers have been swapped today already and options activity is elevated.</li> <li>Skechers sits roughly at the mid-point of its 52-week range of $18.81 to $32.71.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3270731\" data-linked=\"Volatility on Skechers picks up\" data-tweet=\"$SKX - Volatility on Skechers picks up https://seekingalpha.com/news/3270731-volatility-on-skechers-picks-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3270731-volatility-on-skechers-picks-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270729\" data-ts=\"1496240342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTX\" target=\"_blank\">CYTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270729-barda-to-pay-cytori-13_4m-for-development-costs-of-dcctminus-10-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BARDA to pay Cytori $13.4M for development costs of DCCT-10; shares up 2%</a></h4><ul><li>The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority &#40;BARDA&#41; <a href=\"https://seekingalpha.com/filing/3574276\" target=\"_blank\">exercises its rights</a> under Option 2 of its contract with Cytori Therapeutics (<a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a> <font color='green'>+2%</font>) for the development of Cytori Cell Therapy (DCCT-10) as an adjunct therapy in thermal burn injury.</li><li>Under the terms of agreement, BARDA will pay Cytori $13.4M for reimbursement of development costs plus a fixed fee. The company is responsible for additional costs in excess of the funding amount.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270729\" data-linked=\"BARDA to pay Cytori $13.4M for development costs of DCCT-10; shares up 2%\" data-tweet=\"$CYTX $PSTV - BARDA to pay Cytori $13.4M for development costs of DCCT-10; shares up 2% https://seekingalpha.com/news/3270729-barda-to-pay-cytori-13_4m-for-development-costs-of-dcctminus-10-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3270729-barda-to-pay-cytori-13_4m-for-development-costs-of-dcctminus-10-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270730\" data-ts=\"1496240267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270730-miners-drop-iron-ore-prices-sink-to-six-month-lows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Miners drop as iron ore prices sink to six-month lows</a></h4><ul>     <li>Shares in global miners and steel producers are under pressure after <a href=\"https://www.ft.com/content/05b4a04d-3556-3a71-b74c-e991faac3fa9\" target=\"_blank\">iron ore prices plunged</a> to their lowest levels in six months, as stockpiles at Chinese ports swell to their <a href=\"http://www.reuters.com/article/us-ironore-china-idUSKBN18R0DO\" target=\"_blank\">largest in 13 years</a>.</li>     <li>Iron ore prices fell 6% on the Dalian Commodity Exchange as traders returned form the Dragon Boat Festival holiday; the price of physical iron ore for delivery to China traded at $57.02/metric ton today, down from a YTD peak of $95/ton in February.</li>     <li>Imported iron ore at China's ports reached 136.6M metric ton last week, the highest since the SteelHome consultancy began tracking the data in 2004.</li><li>In early trading: <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='red'>-2%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='red'>-2.3%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-3.8%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='red'>-7.2%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-2.7%</font>, <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-3.4%</font>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='red'>-3.6%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='red'>-1.9%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='red'>-3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270730\" data-linked=\"Miners drop as iron ore prices sink to six-month lows\" data-tweet=\"$BHP $BHP $RIO - Miners drop as iron ore prices sink to six-month lows https://seekingalpha.com/news/3270730-miners-drop-iron-ore-prices-sink-to-six-month-lows?source=tweet\" data-url=\"https://seekingalpha.com/news/3270730-miners-drop-iron-ore-prices-sink-to-six-month-lows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270723\" data-ts=\"1496239079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270723-big-banks-under-pressure-execs-suggest-q2-revenue-slowdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big banks under pressure as execs suggest Q2 revenue slowdown</a></h4><ul><li>Speaking at an investor conference, Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='red'>-3%</font>) CEO Brian Moynihan says to expect a year-over-year decline in Q2 trading revenue. Holding court at another conference, JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='red'>-1.8%</font>) CFO Marianne Lake tells listeners that trading revenue is tracking lower by 15% Y/Y in Q2, and she's not expecting that trend to change in June.</li><li>Other players: Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='red'>-2.1%</font>), Goldman Sachs (<a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a> <font color='red'>-2.4%</font>), Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='red'>-1.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270723\" data-linked=\"Big banks under pressure as execs suggest Q2 revenue slowdown\" data-tweet=\"$BAC $BAC $JPM - Big banks under pressure as execs suggest Q2 revenue slowdown https://seekingalpha.com/news/3270723-big-banks-under-pressure-execs-suggest-q2-revenue-slowdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3270723-big-banks-under-pressure-execs-suggest-q2-revenue-slowdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270722\" data-ts=\"1496238990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270722-tevas-fremanezumab-successful-in-late-stage-migraine-study-u-s-marketing-application-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva&#39;s fremanezumab successful in late-stage migraine study; U.S. marketing application expected this year; shares up 1%</a></h4><ul><li>A Phase 3 clinical trial, HALO, assessing Teva Pharmaceutical Industries' (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+0.5%</font>) fremanezumab for the prevention of migraine met all primary and secondary endpoints. Patients treated with the monoclonal antibody experienced a <a href=\"https://seekingalpha.com/pr/16847667-teva-announces-positive-results-phase-iii-study-fremanezumab-prevention-chronic-migraine\" target=\"_blank\">statistically significant reduction</a> in the number of monthly headache days of a least moderate severity compared to placebo over a 12-week treatment period.</li><li>Top-line results from HALO in episodic migraine will be reported in the next few weeks.</li><li>The company says it plans to file a Biologics License Application &#40;BLA&#41; with the FDA this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270722\" data-linked=\"Teva&#39;s fremanezumab successful in late-stage migraine study; U.S. marketing application expected this year; shares up 1%\" data-tweet=\"$TEVA - Teva&#39;s fremanezumab successful in late-stage migraine study; U.S. marketing application expected this year; shares up 1% https://seekingalpha.com/news/3270722-tevas-fremanezumab-successful-in-late-stage-migraine-study-u-s-marketing-application-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3270722-tevas-fremanezumab-successful-in-late-stage-migraine-study-u-s-marketing-application-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270721\" data-ts=\"1496238945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270721-ericsson-on-move-in-wake-of-cevian-investment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ericsson on move in wake of Cevian investment</a></h4><ul>   <li>Ericsson is up in <a href=\"https://seekingalpha.com/news/3270544-ericsson-rallies-activist-cevian-takes-5-percent-stake\" target=\"_blank\">Swedish and U.S. trading today</a> after late word yesterday that Cevian Capital said it had taken a 5.6B stake, betting on the future of the company.</li>    <li>In Stockholm, moves are tracking earlier gains in the company's ADRs, with Ericsson's B shares <font color='green'>up 5.4%</font> and A shares <font color='green'>up 6.9%</font> -- each at their highest point since last summer.</li>    <li>Today on Nasdaq, ADRs are trading <font color='green'>up 1.4%</font> following <font color='green'>gains of 2.9%</font> yesterday.</li>    <li>Cevian's making a welcome investment, the company says, and Cevian plans to propose a managing partner as a member of the nomination committee.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270721\" data-linked=\"Ericsson on move in wake of Cevian investment\" data-tweet=\"Ericsson on move in wake of Cevian investment https://seekingalpha.com/news/3270721-ericsson-on-move-in-wake-of-cevian-investment?source=tweet\" data-url=\"https://seekingalpha.com/news/3270721-ericsson-on-move-in-wake-of-cevian-investment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270716\" data-ts=\"1496237874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270716-alnylams-givosiran-breakthrough-therapy-for-acute-hepatic-porphyria-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alnylam&#39;s givosiran a Breakthrough Therapy for acute hepatic porphyria; shares ahead 2%</a></h4><ul><li>The DFA <a href=\"https://seekingalpha.com/pr/16847500-fda-grants-breakthrough-therapy-designation-alnylam-s-givosiran-prophylaxis-attacks-patients\" target=\"_blank\">designates</a> Alnylam Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='green'>+1.5%</font>) givosiran (ALN-AS1) a Breakthrough Therapy for the prevention of attacks in patients with&nbsp;<a href=\"https://ghr.nlm.nih.gov/condition/porphyria\" target=\"_blank\">acute hepatic porphyria</a>, a disorder caused by abnormalities in the chemical steps that lead to the production of heme, a key molecule for the body's organs.</li><li>Givosiran is an RNAi therapeutic that targets an enzyme called aminolevulinic acid synthase 1 (ALAS1). A Phase 3 study will be initiated in Q4.</li><li>Breakthrough Therapy status provides for more intensive guidance from the FDA, the involvement of more senior agency personnel and a rolling review of the New Drug Application &#40;NDA&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270716\" data-linked=\"Alnylam&#39;s givosiran a Breakthrough Therapy for acute hepatic porphyria; shares ahead 2%\" data-tweet=\"$ALNY - Alnylam&#39;s givosiran a Breakthrough Therapy for acute hepatic porphyria; shares ahead 2% https://seekingalpha.com/news/3270716-alnylams-givosiran-breakthrough-therapy-for-acute-hepatic-porphyria-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3270716-alnylams-givosiran-breakthrough-therapy-for-acute-hepatic-porphyria-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270712\" data-ts=\"1496237243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270712-nq-mobileminus-4_4-after-divestment-snag\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ Mobile -4.4% after divestment snag</a></h4><ul>     <li>NQ Mobile (NQ) is <font color='red'>off 4.4%</font> premarket after noting a <a href=\"https://seekingalpha.com/pr/16847652-nq-mobile-inc-provides-update-divestment-fl-mobile-showself-businesses\" target=\"_blank\">snag in the divestment</a> of a pair of operations.</li>     <li>The company says it's heard from the purchaser, Tongfang Investment Fund Series SPC, that it needs more time to pay the rest of the purchase price for FL Mobile Jiutian Technology and Beijing Showself Technology.</li>     <li>Tongfang has noted its confidence it can complete the deals, NQ Mobile says, and it will work with Tongfang to get the deals closed.</li>   <li>Tongfang was set to <a href=\"https://seekingalpha.com/news/3254449-nq-mobile-plus-9_7-percent-deals-divest-fl-mobile-sell-showself-business\" target=\"_blank\">pay 150M yuan ($22M) as earnest money</a> in March, with the remainder of some 3.32B yuan (about $487M) to come by today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270712\" data-linked=\"NQ Mobile -4.4% after divestment snag\" data-tweet=\"$LKM - NQ Mobile -4.4% after divestment snag https://seekingalpha.com/news/3270712-nq-mobileminus-4_4-after-divestment-snag?source=tweet\" data-url=\"https://seekingalpha.com/news/3270712-nq-mobileminus-4_4-after-divestment-snag\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270710\" data-ts=\"1496236836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270710-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/MEIP' title='MEI Pharma, Inc.'>MEIP</a> <font color='green'>+17%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16847692-mei-pharma-announces-pre-specified-response-rate-exceeded-dose-escalation-studyminus-401\" target=\"_blank\">completion</a> of its pre-specified review of the first cohort of six evaluable patients in a Phase Ib.</li>     <li><a href='https://seekingalpha.com/symbol/JILL' title='J. Jill Group, Inc.'>JILL</a> <font color='green'>+14%&nbsp;</font>on Q1 <a href=\"https://seekingalpha.com/news/3270637-j-jill-reports-q1-results\" target=\"_blank\">earning</a>.</li>     <li>ETRM <font color='green'>+11%</font>&nbsp;on successfully <a href=\"https://seekingalpha.com/pr/16847412-enteromedics-announces-first-vbloc-neurometabolic-therapy-implant-amita-health-adventist\" target=\"_blank\">completing</a> its first implant of the Company's vBloc&nbsp;Neurometabolic Therapy.</li>     <li><a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a> <font color='green'>+9%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16847627-catalyst-biosciences-factor-ix-recommended-orphan-drug-designation-europe\" target=\"_blank\">receiving</a> positive opinion recommending orphan medicinal product designation for CB 2679d/ISU304 for the treatment of hemophilia B.</li>     <li><a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a> <font color='green'>+7%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3270667-analog-devices-beats-0_19-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a> <font color='green'>+6%</font>&nbsp;on completing enrollment of replapsed &nbsp;/ refractory AML patient.</li>     <li><a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='green'>+5%</font>on senior notes <a href=\"https://seekingalpha.com/news/3270676-hertz-repay-old-debt-new-note-issuance\" target=\"_blank\">offering</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270710\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$MEIP $JILL $RSLS - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3270710-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3270710-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270709\" data-ts=\"1496236706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOLD\" target=\"_blank\">FOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270709-amicus-sdminus-101-gets-rare-pediatric-disease-tag-from-fda-for-rare-skin-blistering-disorder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amicus&#39; SD-101 gets rare pediatric disease tag from FDA for rare skin blistering disorder; shares ahead 3% premarket</a></h4><ul><li>Amicus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>) is up&nbsp;<font color='green'>3%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16847511-amicus-therapeutics-receives-rare-pediatric-disease-designation-sdminus-101-patients\" target=\"_blank\">announcement </a>the FDA has granted Rare Pediatric Disease designation for topical med SD-101 for the treatment of a rare inherited disorder called epidermolysis bullosa, a condition characterized by skin blisters and lesions.</li><li>If SD-101 is approved for use in the U.S., the company will receive a priority review voucher that it can used for accelerated review of a future product or it can be sold or transferred to another party.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270709\" data-linked=\"Amicus&#39; SD-101 gets rare pediatric disease tag from FDA for rare skin blistering disorder; shares ahead 3% premarket\" data-tweet=\"$FOLD - Amicus&#39; SD-101 gets rare pediatric disease tag from FDA for rare skin blistering disorder; shares ahead 3% premarket https://seekingalpha.com/news/3270709-amicus-sdminus-101-gets-rare-pediatric-disease-tag-from-fda-for-rare-skin-blistering-disorder?source=tweet\" data-url=\"https://seekingalpha.com/news/3270709-amicus-sdminus-101-gets-rare-pediatric-disease-tag-from-fda-for-rare-skin-blistering-disorder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270704\" data-ts=\"1496236212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270704-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li>KORS&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3270650-soft-guidance-sends-michael-kors-spiraling\" target=\"_blank\">lower guidance</a>.</li><li><a href='https://seekingalpha.com/symbol/JRVR' title='James River Group Holdings'>JRVR</a> <font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16847034-james-river-group-holdings-announces-secondary-offering\" target=\"_blank\">announcing</a> secondary offering.</li><li><a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a> <font color='red'>-5%</font>&nbsp;on providing <a href=\"https://seekingalpha.com/pr/16847443-acacia-communications-provides-business-update\" target=\"_blank\">business update</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3270704\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$CPRI $JRVR $ACIA - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3270704-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3270704-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270703\" data-ts=\"1496236096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEMP\" target=\"_blank\">GEMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270703-gemphire-down-15-premarket-on-ceo-departure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gemphire down 15% premarket on CEO departure</a></h4><ul><li>Thinly traded micro cap Gemphire Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a>) slumps&nbsp;<font color='red'>15%&nbsp;</font>premarket on average volume. After the close yesterday, the company announced that CEO Mina Sooch resigned on May 23 for personal reasons.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270549-gemphire-ceo-steps\" target=\"_blank\">Gemphire CEO steps down</a> (May 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270703\" data-linked=\"Gemphire down 15% premarket on CEO departure\" data-tweet=\"$GEMP - Gemphire down 15% premarket on CEO departure https://seekingalpha.com/news/3270703-gemphire-down-15-premarket-on-ceo-departure?source=tweet\" data-url=\"https://seekingalpha.com/news/3270703-gemphire-down-15-premarket-on-ceo-departure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270701\" data-ts=\"1496235898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGYP\" target=\"_blank\">SGYP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270701-prescription-trends-for-synergys-trulance-ahead-of-projections-shares-ahead-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prescription trends for Synergy&#39;s Trulance ahead of projections, shares ahead 2% premarket</a></h4><ul><li>Synergy Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;premarket on modest volume on the heels of a <a href=\"https://www.streetinsider.com/Analyst+Comments/Synergy+Pharmaceuticals+%28SGYP%29+Trulance+Weekly+Rx+Trends+Continue+to+Track+Ahead+of+Projections+-+BTIG/12960826.html\" target=\"_blank\">note </a>from BTIG Research's Timothy Chiang saying prescription trends for CIC med <a href=\"https://www.trulancehcp.com/\" target=\"_blank\">TRULANCE </a>(plecanatide) are tracking ahead of projections, now more than 800/week. He adds that the company should be able to meet it 2017 sales estimate of ~$21.5M. Refills are also beginning to ramp.</li><li>Mr. Chiang reiterates his peak sales estimate of ~$500M by 2022.</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3270701\" data-linked=\"Prescription trends for Synergy&#39;s Trulance ahead of projections, shares ahead 2% premarket\" data-tweet=\"$SGYP $SGYP-OLD - Prescription trends for Synergy&#39;s Trulance ahead of projections, shares ahead 2% premarket https://seekingalpha.com/news/3270701-prescription-trends-for-synergys-trulance-ahead-of-projections-shares-ahead-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3270701-prescription-trends-for-synergys-trulance-ahead-of-projections-shares-ahead-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>107&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270699\" data-ts=\"1496235739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPR\" target=\"_blank\">TPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270699-coach-sets-up-credit-facility-for-kate-spade-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coach sets up credit facility for Kate Spade buy</a></h4><ul> <li>Coach (COH) lands a $2B credit facility to help the company pay for the acquisiton of Kate Spade.</li> <li>Tranches of $800M for 6 months, $300M at three years and $900M at five years were set up.</li> <li>Coach's foreign subsidiaries can be set up to borrow from the credit facility down the road.</li> <li><a href=\"https://seekingalpha.com/filing/3574105\" target=\"_blank\">SEC Form 8-K</a></li> <li>COH <font color='red'>-0.80%</font> premarket to $45.70.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270699\" data-linked=\"Coach sets up credit facility for Kate Spade buy\" data-tweet=\"$TPR - Coach sets up credit facility for Kate Spade buy https://seekingalpha.com/news/3270699-coach-sets-up-credit-facility-for-kate-spade-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3270699-coach-sets-up-credit-facility-for-kate-spade-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270700\" data-ts=\"1496235571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270700-crude-oil-tumbles-2-libya-hikes-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil tumbles more than 2% as Libya hikes production</a></h4><ul><li><a href=\"http://www.cnbc.com/2017/05/30/oil-falls-as-rising-libyan-us-output-undermines-cuts.html\" target=\"_blank\">Crude oil prices slide sharply lower</a> on news that Libya is raising production, adding to concerns that OPEC-led cuts are being undermined by producers outside the deal; U.S. crude <font color='red'>-2.1%</font> at $48.58/bbl, Brent <font color='red'>-2.6%</font> at $50.50/bbl.</li><li>Libya's oil production is expected to regain a three-year production  peak of 800K bbl/day this week, the country's National Oil Corporation says, as output at its largest oil field has recovered from a technical problem and is now at the 794K bbl/day level - 300K bbl/day higher than a month ago.</li><li>Meanwhile, U.S. output has climbed to more than 9.3M bbl/day, close to top producers Saudi Arabia and Russia.</li><li>Also weighing on the price is the generally negative tone arising from last week's meeting, where the production cut extension already  had been baked into the oil price, disappointing investors and traders who were looking  for deeper cuts than the original 1.8M bbl/day.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/PXE' title='PowerShares Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='PowerShares Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Guggenheim S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3270700\" data-linked=\"Crude oil tumbles more than 2% as Libya hikes production\" data-tweet=\"$USO $OIL $XLE - Crude oil tumbles more than 2% as Libya hikes production https://seekingalpha.com/news/3270700-crude-oil-tumbles-2-libya-hikes-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3270700-crude-oil-tumbles-2-libya-hikes-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270691\" data-ts=\"1496235200\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBVX\" target=\"_blank\">MBVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270691-mabvax-inks-car-t-development-deal-leading-u-s-cancer-center-shares-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MabVax inks CAR-T development deal with leading U.S. cancer center; shares up 2% premarket</a></h4><ul><li>MabVax Therapeutics (<a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a>) perks up&nbsp;<font color='green'>2%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16847471-mabvax-therapeutics-signs-research-agreement-memorial-sloan-kettering-cancer-center-develop\" target=\"_blank\">announcement </a>of a sponsored research agreement with Memorial Sloan Kettering &#40;MSK&#41;&nbsp;Cancer Center for the development of Chimeric Antigen Receptor &#40;CAR&#41; T-cell therapeutics using antibody-targeting sequences derived from its fully human antibodies for pancreatic, small cell lung and other solid tumor cancers.</li><li>Under the terms of the agreement, MabVax will provided the funding to assess the efficacy of multiple CAR-T therapies based on several different antibody-targeting sequences. The company has certain rights to the new CAR-T inventions developed under the collaboration, including an exclusive (time-limited) option to license MSK's rights to such inventions.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270691\" data-linked=\"MabVax inks CAR-T development deal with leading U.S. cancer center; shares up 2% premarket\" data-tweet=\"$MBVX $MBVXQ - MabVax inks CAR-T development deal with leading U.S. cancer center; shares up 2% premarket https://seekingalpha.com/news/3270691-mabvax-inks-car-t-development-deal-leading-u-s-cancer-center-shares-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3270691-mabvax-inks-car-t-development-deal-leading-u-s-cancer-center-shares-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270679\" data-ts=\"1496233502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADI\" target=\"_blank\">ADI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270679-analog-devices-beats-revenue-eps-shares-up-over-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analog Devices beats revenue, EPS; shares up over 6% premarket</a></h4><ul><li>Analog Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a>) Q2 report beat EPS and revenue estimates. Other key metrics include 69.3% gross margin and 37.9% operating margin.</li><li>Notable event: Closed acquisition of Linear Technology Corporation during quarter, which contributed $208.3M to the overall revenue of $1.2B. Q3 will mark first full quarter with Linear Technology products.</li><li>Quarterly dividend declared at $0.45 per outstanding share paid on June 20 to shareholders of record by June 9.</li><li>Q3 revenue guidance is between $1.37B and $1.45B with even the low end coming in slightly above the $1.36B consensus estimate.</li><li>Analog Devices&rsquo; shares are&nbsp;<font color='green'>up 6.1%&nbsp;</font>premarket.</li><li><a href=\"https://seekingalpha.com/pr/16847555-analog-devices-reports-second-quarter-2017-results\" target=\"_blank\">Press Release</a></li><li>Previously: <b><u>Analog Devices beats by $0.19, beats on revenue</u></b> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270679\" data-linked=\"Analog Devices beats revenue, EPS; shares up over 6% premarket\" data-tweet=\"$ADI - Analog Devices beats revenue, EPS; shares up over 6% premarket https://seekingalpha.com/news/3270679-analog-devices-beats-revenue-eps-shares-up-over-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3270679-analog-devices-beats-revenue-eps-shares-up-over-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270678\" data-ts=\"1496233041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRA\" target=\"_blank\">VRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270678-vera-bradley-positive-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vera Bradley positive post Q1 results</a></h4><ul>     <li>Vera Bradley (NASDAQ:<a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a>)&nbsp;reports comparable sales fell 12.5% in <a href=\"https://seekingalpha.com/pr/16847587-vera-bradley-announces-fiscal-first-quarter-2018-results\" target=\"_blank\">Q1</a>&nbsp;due to&nbsp;declines in store and e-commerce traffic.</li>     <li>Direct segment revenue dropped 5.6% to $68.8M.</li>     <li>Indirect segment revenue down 15.3% to $27.3M.</li>     <li>E-commerce sales reduced 22% Y/Y.</li>     <li>Gross margin rate squeezed 190 bps to 54.8% due tochannel mix changes and increased promotional activity at the Company&rsquo;s factory outlet stores.</li>     <li>Adjusted SG&amp;A expense rate up 510 bps to 58.7%.</li>     <li>Inventory -7% Y/Y to $105.42M.</li>     <li><b>Q2 Guidance</b>: Net revenues: $111M to $115M; Gross margin rate: 57.5% to 58%; SG&amp;A expense rate: 53% to 53.5%; Tax rate: 35.6%; Diluted EPS: $0.09 to $0.11; Weighted-average shares outstanding: 35.9M; Inventory: $100M to $110M.</li>     <li><b>FY2018 Guidance</b>:&nbsp;Net revenues: $460M to $480M; Gross margin rate: 56% to 56.5%; SG&amp;A expense rate: 50.8% to 51.3%; Tax rate: 38%; Diluted EPS: $0.40 to $0.50; Weighted-average shares outstanding: 35.8M; Capex: ~$10M to $15M.</li>     <li>VRA<font color='red'>&nbsp;</font><font color='green'>+1.18%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270678\" data-linked=\"Vera Bradley positive post Q1 results\" data-tweet=\"$VRA - Vera Bradley positive post Q1 results https://seekingalpha.com/news/3270678-vera-bradley-positive-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3270678-vera-bradley-positive-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270676\" data-ts=\"1496232915\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270676-hertz-to-repay-old-debt-new-note-issuance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz to repay old debt with new note issuance</a></h4><ul> <li>Hertz Global (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) announces today that intends to offer $1B in senior notes through a subsidiary.</li><li>The company intends to use a portion of the proceeds from the issuance to help redeem a series of other notes. The remaining funds will also go toward other refinancing activities.</li>  <li>HTZ  <font color='green'>+3.40%</font>&nbsp;premarket to  $9.74.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16846978-hertz-global-holdings-announces-proposed-1-billion-private-offering-senior-second-priority\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3270676\" data-linked=\"Hertz to repay old debt with new note issuance\" data-tweet=\"$HTZ - Hertz to repay old debt with new note issuance https://seekingalpha.com/news/3270676-hertz-to-repay-old-debt-new-note-issuance?source=tweet\" data-url=\"https://seekingalpha.com/news/3270676-hertz-to-repay-old-debt-new-note-issuance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270674\" data-ts=\"1496232535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JILL\" target=\"_blank\">JILL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270674-j-jill-defies-mall-slump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J. Jill defies mall slump</a></h4><ul> <li>J. Jill Group (NYSE:<a href='https://seekingalpha.com/symbol/JILL' title='J. Jill Group, Inc.'>JILL</a>) is doing something right amid what most of its mall peers call a \"challenging\" retail backdrop.</li> <li>The company knocked out comparable sales growth of 9.9% in <a href=\"https://seekingalpha.com/pr/16847397-j-jill-inc-announces-first-quarter-fiscal-2017-results\" target=\"_blank\">Q1</a> and saw its gross margin rate increase 90 bps to 69.6%.</li> <li>Direct to consumer sales accounted for 42.6% of all sales during the quarter.</li> <li>Looking ahead, J. Jill sees Q2 EPS of $0.27 to $0.29 vs. $0.27 consensus and full-year EPS of $0.80 to $0.84 vs. $0.75 to $0.79 prior and $0.79 consensus.</li> <li>Shares of Jill are <font color='green'>up 10.91%</font> premarket to $12.50, still short of the $13 mark where the IPO was priced.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270637-j-jill-reports-q1-results\" target=\"_blank\">J. Jill reports Q1 results</a> (May 31)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270674\" data-linked=\"J. Jill defies mall slump\" data-tweet=\"$JILL - J. Jill defies mall slump https://seekingalpha.com/news/3270674-j-jill-defies-mall-slump?source=tweet\" data-url=\"https://seekingalpha.com/news/3270674-j-jill-defies-mall-slump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270667\" data-ts=\"1496232182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADI\" target=\"_blank\">ADI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270667-analog-devices-beats-0_19-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analog Devices beats by $0.19, beats on revenue</a></h4><ul><li>Analog Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a>): Q2 EPS of $1.03 <font color='green'>beats by $0.19</font>.</li><li>Revenue of $1.2B (+54.1% Y/Y) <font color='green'>beats by $100M</font>.</li><li>Shares <font color='green'>+3.5%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16847555-analog-devices-reports-second-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3270667\" data-linked=\"Analog Devices beats by $0.19, beats on revenue\" data-tweet=\"$ADI - Analog Devices beats by $0.19, beats on revenue https://seekingalpha.com/news/3270667-analog-devices-beats-0_19-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3270667-analog-devices-beats-0_19-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270661\" data-ts=\"1496231808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARI\" target=\"_blank\">ARI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270661-apollo-commercial-down-4_1-after-pricing-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apollo Commercial down 4.1% after pricing secondary</a></h4><ul><li>The company's 12M share sale has reportedly priced at $18.25 per share, well north of Dec. 31 book value of $16.12. The underwriters have an option to buy another 1.8M shares at the offering price.</li><li><a href='https://seekingalpha.com/symbol/ARI' title='Apollo Commercial Real Estate Finance, Inc.'>ARI</a>&nbsp;<font color='red'>-4.1%</font>&nbsp;to $18.20</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270552-apollo-commercial-raising-capital-shares-1_75-percent\" target=\"_blank\">Apollo Commercial raising capital; shares down 1.75%</a> (May 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270661\" data-linked=\"Apollo Commercial down 4.1% after pricing secondary\" data-tweet=\"$ARI - Apollo Commercial down 4.1% after pricing secondary https://seekingalpha.com/news/3270661-apollo-commercial-down-4_1-after-pricing-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3270661-apollo-commercial-down-4_1-after-pricing-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270654\" data-ts=\"1496231363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270654-array-out-licenses-binimetinib-and-encorafenib-to-ono-pharma-for-japan-and-south-korea-for-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array out-licenses binimetinib and encorafenib to Ono Pharma for Japan and South Korea for up to $187.6M; shares ahead 3% premarket</a></h4><ul><li>Array BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>) inks a license, development and commercialization deal with Osaka, Japan-based Ono Pharmaceutical (<a href='https://seekingalpha.com/symbol/OPHLF' title='Ono Pharmaceutical Co., Ltd.'>OTC:OPHLF</a>)(<a href='https://seekingalpha.com/symbol/OPHLY' title='Ono Pharmaceutical Co., Ltd. ADR'>OTCPK:OPHLY</a>) for the rights to develop and commercialize binimetinib and encorafenib in Japan and South Korea.</li><li>Under the terms of the <a href=\"https://seekingalpha.com/pr/16847291-array-biopharma-ono-pharmaceutical-co-ltd-announce-license-development-commercialization\" target=\"_blank\">agreement</a>, Array will receive an upfront payment of &yen;3.5 billion ($31.6M), up to &yen;17.3 billion ($156M) in milestones and tiered, double-digit royalties on net sales in the territory. Ono will also contribute 12% of the costs of all future global development of the two compounds.</li><li>ARRY is up&nbsp;<font color='green'>3%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270654\" data-linked=\"Array out-licenses binimetinib and encorafenib to Ono Pharma for Japan and South Korea for up to $187.6M; shares ahead 3% premarket\" data-tweet=\"$ARRY $ARRY $OPHLF - Array out-licenses binimetinib and encorafenib to Ono Pharma for Japan and South Korea for up to $187.6M; shares ahead 3% premarket https://seekingalpha.com/news/3270654-array-out-licenses-binimetinib-and-encorafenib-to-ono-pharma-for-japan-and-south-korea-for-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3270654-array-out-licenses-binimetinib-and-encorafenib-to-ono-pharma-for-japan-and-south-korea-for-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270657\" data-ts=\"1496230665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270657-walgreens-seen-taking-rite-aid-fight-to-court\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walgreens seen taking Rite Aid fight to court</a></h4><ul>     <li>Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) is likely to take the FTC to court if the proposed merger with Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) is blocked, according to Cowen and Company.</li>     <li>The investment firm works out the math on Outperform-rated Rite Aid to derive a $9.21 valuation off of synergies of $7.65 per share and a $2 standalone value subtracted by $0.44 in divestitures.</li>     <li>Source: Bloomberg</li>     <li>In premarket action, WBA is&nbsp;<font color='green'>up 0.10%</font>&nbsp;and RAD is <font color='green'>1.16% higher</font> to $3.50. Keep an eye on Fred's (NASDAQ:<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a>) as well to move off the latest drugstore sector news.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270657\" data-linked=\"Walgreens seen taking Rite Aid fight to court\" data-tweet=\"$WBA $WBA $RAD - Walgreens seen taking Rite Aid fight to court https://seekingalpha.com/news/3270657-walgreens-seen-taking-rite-aid-fight-to-court?source=tweet\" data-url=\"https://seekingalpha.com/news/3270657-walgreens-seen-taking-rite-aid-fight-to-court\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>169&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270650\" data-ts=\"1496230111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRI\" target=\"_blank\">CPRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270650-soft-guidance-sends-michael-kors-spiraling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soft guidance sends Michael Kors spiraling</a></h4><ul> <li>Michael Kors (KORS) slides after posting somewhat disappointing <a href=\"https://seekingalpha.com/pr/16847406-michael-kors-holdings-limited-announces-fourth-quarter-annual-fiscal-2017-results\" target=\"_blank\">Q1 results</a> and issuing guidance below expectations.</li> <li>Comparable sales fell 13.6% during the quarter vs. -12.3% consensus to take the shine off an EPS beat.</li> <li>\"Our product and store experience did not sufficiently engage and excite consumers. We acknowledge that we need to take further steps to elevate the level of fashion innovation in our accessories assortments and enhance our store experience in order to deepen consumer desire and demand for our products,\" observes Kors CEO John Idol.</li> <li>Looking ahead, the company sees FQ1 revenue of $910M to $930M vs. $944.2M consensus and FQ1 EPS of $0.60 to $0.64 vs. $0.80 consensus.</li> <li>A new $1B buyback plan approved by the Kors board isn't enough to keep investors satisfied, shares are <font color='red'>down 8.08%</font> in premarket action.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270638-michael-kors-holdings-beats-0_03-beats-revenue\" target=\"_blank\">Michael Kors Holdings beats by $0.03, beats on revenue</a> (May 31)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270650\" data-linked=\"Soft guidance sends Michael Kors spiraling\" data-tweet=\"$CPRI - Soft guidance sends Michael Kors spiraling https://seekingalpha.com/news/3270650-soft-guidance-sends-michael-kors-spiraling?source=tweet\" data-url=\"https://seekingalpha.com/news/3270650-soft-guidance-sends-michael-kors-spiraling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":66,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}